Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target?
出版年份 2019 全文链接
标题
Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target?
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 3, Pages 558
出版商
MDPI AG
发表日期
2019-01-29
DOI
10.3390/ijms20030558
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evaluating Potential QT Effects of JNJ-54861911, a BACE Inhibitor in Single- and Multiple-Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration-QTc Analysis
- (2018) Maarten Timmers et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Alzheimer's disease research: the future of BACE inhibitors
- (2018) Talha Burki LANCET
- ABBY
- (2018) Jeffrey L. Cummings et al. NEUROLOGY
- A Next Generation Synthesis of BACE1 Inhibitor Verubecestat (MK-8931)
- (2018) David A. Thaisrivongs et al. ORGANIC LETTERS
- Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β
- (2018) Joseph W. Arndt et al. Scientific Reports
- Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain
- (2018) John A. Hey et al. CNS DRUGS
- The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
- (2018) Ulf Neumann et al. EMBO Molecular Medicine
- Pharmacokinetics of tazarotene and acitretin in psoriasis
- (2018) Michael S. Heath et al. Expert Opinion on Drug Metabolism & Toxicology
- Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β
- (2018) Bernd Bohrmann et al. JOURNAL OF ALZHEIMERS DISEASE
- Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer’s disease mouse model
- (2018) Joseph Flores et al. Nature Communications
- Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study
- (2018) Maarten Timmers et al. Alzheimers Research & Therapy
- Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer’s disease (BLAZE)
- (2018) Stephen Salloway et al. Alzheimers Research & Therapy
- BACE1 Inhibitor MK-8931 Alters Formation but Not Stability of Dendritic Spines
- (2018) Tanja Blume et al. Frontiers in Aging Neuroscience
- FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease
- (2018) Petr Novak et al. Alzheimers Research & Therapy
- The Function of the Mitochondrial Calcium Uniporter in Neurodegenerative Disorders
- (2017) Yajin Liao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial
- (2017) Gordon K. Wilcock et al. JOURNAL OF ALZHEIMERS DISEASE
- Acitretin Use in Dermatology
- (2017) Lyn C. Guenther et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Aducanumab Therapy Ameliorates Calcium Overload in a Mouse Model of Alzheimer's Disease
- (2017) Kanchana K. Gamage et al. JOURNAL OF NEUROSCIENCE
- Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
- (2017) Petr Novak et al. LANCET NEUROLOGY
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease
- (2017) Scott C. Neu et al. JAMA Neurology
- Amyloid-β Induces Caspase-Dependent Loss of PSD-95 and Synaptophysin Through NMDA Receptors
- (2017) Jinping Liu et al. JOURNAL OF ALZHEIMERS DISEASE
- 2016 Alzheimer's disease facts and figures
- (2016) Alzheimers & Dementia
- Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease
- (2016) Laura Xicota et al. CURRENT DRUG TARGETS
- Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease
- (2016) Eameema Muntimadugu et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Pioglitazone for the treatment of Alzheimer’s disease
- (2016) Daniela Galimberti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease
- (2016) Gvido Cebers et al. JOURNAL OF ALZHEIMERS DISEASE
- AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics
- (2016) Susanna Eketjäll et al. JOURNAL OF ALZHEIMERS DISEASE
- Two Phase 2 Multiple Ascending–Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer’s Disease
- (2016) Florence Pasquier et al. JOURNAL OF ALZHEIMERS DISEASE
- Acitretin
- (2016) Marcus G. Tan et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)–A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer’s Disease
- (2016) Jack D. Scott et al. JOURNAL OF MEDICINAL CHEMISTRY
- Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice
- (2016) Ksenia V. Kastanenka et al. JOURNAL OF NEUROSCIENCE
- Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
- (2016) Serge Gauthier et al. LANCET
- The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
- (2016) Marina Saresella et al. Molecular Neurodegeneration
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- A polarizing question: do M1 and M2 microglia exist?
- (2016) Richard M Ransohoff NATURE NEUROSCIENCE
- Alzheimer’s diseaseCD33rs3865444 variant does not contribute to cognitive performance: Table 1.
- (2016) Guiyou Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer’s disease in rodent models
- (2016) Michael J. D. Daniels et al. Nature Communications
- Amplified RLR signaling activation through an interferon-stimulated gene-endoplasmic reticulum stress-mitochondrial calcium uniporter protein loop
- (2016) Jinbo Cheng et al. Scientific Reports
- CALHM1 deficiency impairs cerebral neuron activity and memory flexibility in mice
- (2016) Valérie Vingtdeux et al. Scientific Reports
- Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement
- (2016) Seung-Hye Lee et al. Cell Reports
- Intracellular Calcium Dysregulation: Implications for Alzheimer’s Disease
- (2016) Simona Magi et al. Biomed Research International
- Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment
- (2016) Jaume Folch et al. NEURAL PLASTICITY
- Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin
- (2016) Mark Ultsch et al. Scientific Reports
- Characterization of Dementia and Alzheimer’s Disease in an Older Population: Updated Incidence and Life Expectancy With and Without Dementia
- (2015) Sarah E. Tom et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Interactions of innate and adaptive immunity in brain development and function
- (2015) Anthony J. Filiano et al. BRAIN RESEARCH
- Microglial M1/M2 polarization and metabolic states
- (2015) Ruben Orihuela et al. BRITISH JOURNAL OF PHARMACOLOGY
- Non-Steroidal Anti-Inflammatory Drugs as a Treatment for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Treatment Effect
- (2015) Marina Miguel-Álvarez et al. DRUGS & AGING
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- TREM2 variants and risk of Alzheimer’s disease: a meta-analysis
- (2015) Yanjun Lu et al. NEUROLOGICAL SCIENCES
- A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
- (2015) R. Scott Turner et al. NEUROLOGY
- Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
- (2015) J. Butchart et al. NEUROLOGY
- Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
- (2015) Sagar H. Barage et al. NEUROPEPTIDES
- Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
- (2015) Neha Atulkumar Singh et al. Nutrition Journal
- Mitochondrial calcium uniporter protein MCU is involved in oxidative stress-induced cell death
- (2015) Yajin Liao et al. Protein & Cell
- First Administration of the Fc-Attenuated Anti-β Amyloid Antibody GSK933776 to Patients with Mild Alzheimer’s Disease: A Randomized, Placebo-Controlled Study
- (2015) Niels Andreasen et al. PLoS One
- Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada
- (2015) Thibault B. Ali et al. PLoS One
- Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
- (2014) Aaron H Burstein et al. BMC Neurology
- The Multifactorial Nature of Alzheimer's Disease for Developing Potential Therapeutics
- (2014) M. Carreiras et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Coding variants in TREM2 increase risk for Alzheimer's disease
- (2014) Sheng Chih Jin et al. HUMAN MOLECULAR GENETICS
- Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
- (2014) Jia Xue et al. IMMUNITY
- Cytokine-Mediated Inhibition of Fibrillar Amyloid- Peptide Degradation by Human Mononuclear Phagocytes
- (2014) M. Yamamoto et al. JOURNAL OF IMMUNOLOGY
- Sex and gender differences in the causes of dementia: A narrative review
- (2014) Walter A. Rocca et al. MATURITAS
- Increased CSF APPs- levels in patients with Alzheimer disease treated with acitretin
- (2014) K. Endres et al. NEUROLOGY
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence of Trem2 Variant Associated with Triple Risk of Alzheimer’s Disease
- (2014) Zainularifeen Abduljaleel et al. PLoS One
- Clioquinol promotes the degradation of metal-dependent amyloid- (A ) oligomers to restore endocytosis and ameliorate A toxicity
- (2014) K. E. S. Matlack et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modulation of β-amyloid by a single dose of GSK933776 in patients with mild Alzheimer’s disease: a phase I study
- (2014) Thomas Leyhe et al. Alzheimers Research & Therapy
- First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
- (2014) Eva Kontsekova et al. Alzheimers Research & Therapy
- Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences
- (2014) Michelle Mielke et al. Clinical Epidemiology
- Microglia Promote Learning-Dependent Synapse Formation through Brain-Derived Neurotrophic Factor
- (2013) Christopher N. Parkhurst et al. CELL
- Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
- (2013) Bin Zhang et al. CELL
- Canonical Nlrp3 Inflammasome Links Systemic Low-Grade Inflammation to Functional Decline in Aging
- (2013) Yun-Hee Youm et al. Cell Metabolism
- Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease
- (2013) Jaren W. Landen et al. CLINICAL NEUROPHARMACOLOGY
- Impact of Apolipoprotein E on Alzheimer’s Disease
- (2013) Paul Hauser et al. Current Alzheimer Research
- Bapineuzumab and solanezumab for Alzheimer's disease: is the ‘amyloid cascade hypothesis' still alive?
- (2013) Haythum O Tayeb et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Genome-Wide Association Studies, Alzheimer Disease, and Understudied Populations
- (2013) Robert L. Nussbaum JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CALHM1 controls the Ca2+-dependent MEK, ERK, RSK and MSK signaling cascade in neurons
- (2013) U. Dreses-Werringloer et al. JOURNAL OF CELL SCIENCE
- NLRP3 polymorphisms are associated with late-onset Alzheimer's disease in Han Chinese
- (2013) Meng-Shan Tan et al. JOURNAL OF NEUROIMMUNOLOGY
- The NLRP3 Inflammasome in Alzheimer’s Disease
- (2013) Meng-Shan Tan et al. MOLECULAR NEUROBIOLOGY
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
- (2013) Jean-Charles Lambert et al. NATURE GENETICS
- NLRP3 inflammasome activation: CD36 serves double duty
- (2013) Jonathan C Kagan et al. NATURE IMMUNOLOGY
- CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
- (2013) Frederick J Sheedy et al. NATURE IMMUNOLOGY
- CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
- (2013) Elizabeth M Bradshaw et al. NATURE NEUROSCIENCE
- Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
- (2013) L. E. Hebert et al. NEUROLOGY
- Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
- (2013) Ana Griciuc et al. NEURON
- Microglia Actively Regulate the Number of Functional Synapses
- (2013) Kyungmin Ji et al. PLoS One
- Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia
- (2013) Michael J. Berridge Prion
- Alzheimer disease
- (2013) Justin M. Nussbaum et al. Prion
- Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation
- (2013) Wai T. Wong Frontiers in Cellular Neuroscience
- Profile of gantenerumab and its potential in the treatment of Alzheimer's disease
- (2013) Robert Nisticò et al. Drug Design Development and Therapy
- Early-onset Alzheimer's Disease: Nonamnestic Subtypes and Type 2 AD
- (2012) Mario F. Mendez ARCHIVES OF MEDICAL RESEARCH
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- Effects of Single Doses of Avagacestat (BMS-708163) on Cerebrospinal Fluid Aβ Levels in Healthy Young Men
- (2012) Gary Tong et al. CLINICAL DRUG INVESTIGATION
- A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects
- (2012) Randy Dockens et al. CLINICAL PHARMACOKINETICS
- Gantenerumab for the treatment of Alzheimer's disease
- (2012) Julien Delrieu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Cognitive reserve in ageing and Alzheimer's disease
- (2012) Yaakov Stern LANCET NEUROLOGY
- TPI-287, a New Taxane Family Member, Reduces the Brain Metastatic Colonization of Breast Cancer Cells
- (2012) D. P. Fitzgerald et al. MOLECULAR CANCER THERAPEUTICS
- Aβ Toxicity in Alzheimer's Disease
- (2012) Virve Cavallucci et al. MOLECULAR NEUROBIOLOGY
- NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
- (2012) Michael T. Heneka et al. NATURE
- Etazolate, an α-secretase activator, reduces neuroinflammation and offers persistent neuroprotection following traumatic brain injury in mice
- (2012) Eleni Siopi et al. NEUROPHARMACOLOGY
- Variant of TREM2 Associated with the Risk of Alzheimer's Disease
- (2012) Thorlakur Jonsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- TREM2 Variants in Alzheimer's Disease
- (2012) Rita Guerreiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advances in the pathogenesis of Alzheimer's disease: a re-evaluation of amyloid cascade hypothesis
- (2012) Dong Suzhen et al. Translational Neurodegeneration
- Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
- (2011) Paul S. Aisen et al. Archives of Medical Science
- Lack of Evidence for the Efficacy of Memantine in Mild Alzheimer Disease
- (2011) Lon S. Schneider ARCHIVES OF NEUROLOGY
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- Tacrine Treatment at High Dose Suppresses the Recognition Memory in Juvenile and Adult Mice with Attention to Hepatotoxicity
- (2011) Si-Yuan Pan et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- The amyloid cascade hypothesis has misled the pharmaceutical industry
- (2011) BIOCHEMICAL SOCIETY TRANSACTIONS
- Structural Basis of C-terminal β-Amyloid Peptide Binding by the Antibody Ponezumab for the Treatment of Alzheimer's Disease
- (2011) Sherry L. La Porte et al. JOURNAL OF MOLECULAR BIOLOGY
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
- (2011) S. Salloway et al. NEUROLOGY
- A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease
- (2011) M. Sano et al. NEUROLOGY
- Physiology of Microglia
- (2011) Helmut Kettenmann et al. PHYSIOLOGICAL REVIEWS
- The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor
- (2011) John P. Duffy et al. ACS Medicinal Chemistry Letters
- A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease
- (2010) David S. Geldmacher et al. ARCHIVES OF NEUROLOGY
- Beyond the Cholinergic Hypothesis: Do Current Drugs Work in Alzheimer's Disease?
- (2010) Alessandro Martorana et al. CNS Neuroscience & Therapeutics
- The secretases: enzymes with therapeutic potential in Alzheimer disease
- (2010) Bart De Strooper et al. Nature Reviews Neurology
- Decreased Clearance of CNS -Amyloid in Alzheimer's Disease
- (2010) K. G. Mawuenyega et al. SCIENCE
- Synaptic degeneration in Alzheimer’s disease
- (2009) Thomas Arendt ACTA NEUROPATHOLOGICA
- Protective actions of sex steroid hormones in Alzheimer’s disease
- (2009) Christian J. Pike et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-β
- (2009) Alessandro Michelucci et al. JOURNAL OF NEUROIMMUNOLOGY
- Effect of tramiprosate in patients with mild-to-moderate alzheimer’s disease: Exploratory analyses of the MRI sub-group of the alphase study
- (2009) S. Gauthier et al. Journal of Nutrition Health & Aging
- APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
- (2009) Anatoly Nikolaev et al. NATURE
- CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
- (2009) Cameron R Stewart et al. NATURE IMMUNOLOGY
- Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
- (2009) Tomohiko Sato et al. NEUROBIOLOGY OF AGING
- Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort
- (2009) J.C.S. Breitner et al. NEUROLOGY
- Calcium signaling and neurodegenerative diseases
- (2009) Ilya Bezprozvanny TRENDS IN MOLECULAR MEDICINE
- The amyloid cascade hypothesis
- (2008) Amos D. Korczyn Alzheimers & Dementia
- Oxidative Stress Signaling in Alzheimers Disease
- (2008) B. Su et al. Current Alzheimer Research
- Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity
- (2008) Kryslaine O. Lopes et al. GLIA
- Etazolate, a neuroprotective drug linking GABAAreceptor pharmacology to amyloid precursor protein processing
- (2008) Maryline Marcade et al. JOURNAL OF NEUROCHEMISTRY
- Microglial Dysfunction and Defective -Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
- (2008) S. E. Hickman et al. JOURNAL OF NEUROSCIENCE
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Protective effects of NSAIDs on the development of Alzheimer disease
- (2008) Steven C. Vlad et al. NEUROLOGY
- ApoE Promotes the Proteolytic Degradation of Aβ
- (2008) Qingguang Jiang et al. NEURON
- Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease
- (2008) Ilya Bezprozvanny et al. TRENDS IN NEUROSCIENCES
- Menopausal transition: A possible risk factor for brain pathologic events
- (2007) S.M. Bonomo et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search